1. SearchSearch for a medicine in our shop and discuss with your doctor. All orders require a doctor's prescription.
2. OrderWe'll support you through the entire administrative process and approval requirements to obtain the medicine.
3. ShippingWe'll get the medicine to you in a timely manner so that your treatment can commence as soon as possible.
— Charles, US
— Tomasz, Poland
— Regina, US
— Stephen, UK
— Dee, Australia
— Haoyu, China
— Frank, US
— Patric, Germany
Opdivo (nivolumab) vs. Keytruda (pembrolizumab) – which will doctors choose? Korea Biomedical Review, September 14, 2017.
Can certain men with prostate cancer benefit from Rubraca (rucaparib), a drug originally developed for ovarian cancer? A phase 3 clinical trial is investigating it. Cure Today, September 18, 2017.
An expert discusses the approval of the first chimeric antigen receptor (CAR) T-cell Therapy – a new era in oncology. Onclive, September 18, 2017.
TheSocialMedwork is a social enterprise aiming to help seriously ill patients access the latest medicines that are not yet available in their own country, but have been approved and are available somewhere else in the world.
TheSocialMedwork is a registered, independent digital health intermediary. We use existing legal processes and speed up the system, sourcing each medicine for every individual patient and arranging for it to be legally imported and delivered to them in their home country.
TheSocialMedwork was started after our three founders lost family members and friends to Cancer and ALS, and felt that they could have been treated more successfully, had they been able to access newly developed medicines in time. These medicines had already been approved in another country, and were already being used to treat patients overseas.
At TheSocialMedwork we believe that the latest approved medicines should be available to each and every patient and physician as quickly as possible - regardless of where they happen to live.